Stage II Uterine Corpus Cancer Clinical Trial
Official title:
The Effectiveness of a Comprehensive Physical Activity Behavioral Intervention on Underserved Diverse Obese Endometrial Cancer Survivors
Verified date | September 2019 |
Source | Albert Einstein College of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This randomized clinical trial studies a physical activity behavioral intervention in obese endometrial cancer survivors. Learning about physical activity behavior while participating in a fitness class may help increase physical activity and improve the quality of life of obese endometrial cancer survivors.
Status | Completed |
Enrollment | 30 |
Est. completion date | June 2018 |
Est. primary completion date | April 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 90 Years |
Eligibility |
Inclusion Criteria: - Written informed consent form signed and dated by the subject - English and/or Spanish speaking - History of endometrial cancer stage I-IV > 6 months < 5 years, not currently receiving cancer treatment - Overweight (body mass index [BMI] >= 30) - Eastern Cooperative Oncology Group performance status (PS) of 0 - 2 - Medically capable of performing moderate intensity exercise Exclusion Criteria: - Must not have engaged in a regular (> 3x/week, physical activity program in the last 6 months) - Medical contraindication to exercise |
Country | Name | City | State |
---|---|---|---|
United States | Albert Einstein College of Medicine | Bronx | New York |
Lead Sponsor | Collaborator |
---|---|
Albert Einstein College of Medicine | National Cancer Institute (NCI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of participants completing at least 150 minutes of moderate-vigorous physical activity, assessed by the Yale Physical Activity Survey (YPAS) | Data will be analyzed using Pearson Chi-square test. | 12 weeks | |
Secondary | Barrier avoidance/coping, measured using 5 point Likert scales | Multiple logistic regression analysis will be used to examine the association of the Social Cognitive Theory behavior variables to physical activity, adjusting for potential confounders. | Up to 12 weeks | |
Secondary | BMI | Will be analyzed using student t-test. When the data are non-normal, investigators will use appropriate nonparametric tests. | Up to 12 weeks | |
Secondary | Change in ability to perform activities of daily living, assessed with the YPAS | Will be analyzed using student t-test. When the data are non-normal, investigators will use appropriate nonparametric tests. | Baseline to 12 weeks | |
Secondary | Change in sedentary time, assessed with the YPAS | Will be analyzed using student t-test. When the data are non-normal, investigators will use appropriate nonparametric tests. | Baseline to 12 weeks | |
Secondary | Exercise efficacy, measured using 5 point Likert scales | Multiple logistic regression analysis will be used to examine the association of the Social Cognitive Theory behavior variables to physical activity, adjusting for potential confounders. | Up to 12 weeks | |
Secondary | Fatigue, assessed by the FACT-Fatigue | Will be analyzed using student t-test. When the data are non-normal, investigators will use appropriate nonparametric tests. | Up to 12 weeks | |
Secondary | Outcome expectations, measured using 5 point Likert scales | Multiple logistic regression analysis will be used to examine the association of the Social Cognitive Theory behavior variables to physical activity, adjusting for potential confounders. | Up to 12 weeks | |
Secondary | Physical function score | Will be analyzed using student t-test. When the data are non-normal, investigators will use appropriate nonparametric tests. | Up to 12 weeks | |
Secondary | Quality of life, assessed by the Functional Assessment of Cancer Therapy (FACT)-Endometrial Cancer | Will be analyzed using student t-test. When the data are non-normal, investigators will use appropriate nonparametric tests. | Up to 12 weeks | |
Secondary | Self-regulation, measured using 5 point Likert scales | Multiple logistic regression analysis will be used to examine the association of the Social Cognitive Theory behavior variables to physical activity, adjusting for potential confounders. | Up to 12 weeks | |
Secondary | Social support, measured using 5 point Likert scales | Multiple logistic regression analysis will be used to examine the association of the Social Cognitive Theory behavior variables to physical activity, adjusting for potential confounders. | Up to 12 weeks | |
Secondary | Waist circumference | Will be analyzed using student t-test. When the data are non-normal, investigators will use appropriate nonparametric tests. | Up to 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01208467 -
Prognostic Biomarkers in Patients With Endometrial Cancer
|
N/A | |
Completed |
NCT01522820 -
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
|
Phase 1 | |
Active, not recruiting |
NCT00956670 -
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
|
N/A | |
Completed |
NCT00897442 -
Collecting Tumor Samples From Patients With Gynecological Tumors
|
N/A | |
Completed |
NCT01098630 -
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
|
||
Recruiting |
NCT03422198 -
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
|
Phase 3 | |
Not yet recruiting |
NCT01199250 -
Biomarkers in Samples From Patients With Endometrial Cancer
|
N/A | |
Not yet recruiting |
NCT01198171 -
Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer
|
N/A | |
Not yet recruiting |
NCT01344837 -
Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer
|
N/A | |
Terminated |
NCT01041027 -
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer
|
Phase 2 | |
Terminated |
NCT00577317 -
Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
|
Phase 3 | |
Completed |
NCT02342730 -
Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia
|
N/A | |
Completed |
NCT03198286 -
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
|
N/A | |
Completed |
NCT00002706 -
Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus
|
Phase 3 |